Cataract surgery saves lives, dollars by reducing auto crashes

Oct 19, 2010

Cataract surgery not only improves vision and quality of life for older people, but is also apparently a way to reduce the number of car crashes. The research will be presented today's at the Scientific Program of the 2010 American Academy of Ophthalmology (AAO) – Middle East-Africa Council of Ophthalmology (MEACO) Joint Meeting. Cataract surgery not only improves vision and quality of life for older people, but is also apparently a way to reduce the number of car crashes. The research will be presented today's at the Scientific Program of the 2010 American Academy of Ophthalmology (AAO) – Middle East-Africa Council of Ophthalmology (MEACO) Joint Meeting.. It is the largest, most comprehensive ophthalmic education conference in the world.

There's no question that good vision is essential to avoiding auto crashes. But what's the actual impact of a common, vision-improving treatment like cataract removal on crash rates? And is it significant enough that health systems should make sure people don't wait months between cataract diagnosis and surgery? To answer these questions researcher Jonathon Ng, MD, studied accident rates for Western Australian residents before and after cataract surgery on the first eye. (Usually a time interval is built in between surgery in the first and second eyes.)

Cataract–when the eye's crystalline lens becomes clouded and hardens–is the leading cause of vision impairment in . By age 60 many people have some lens opacity, and by 70 nearly all have cataract in one or both eyes. Surgical removal of cataract followed by implantation of intraocular lenses dramatically improves vision for most patients.

In Dr. Ng's study, 27,827 patients who had a cataract removed from one eye between 1997 and 2006 were included. Patient records were linked to the Western Australian Road Injury Database to identify those involved in a motor vehicle crash 12 months prior to and 12 months following their surgery dates. All patients were aged 60+ years. The majority of patients involved in crashes were males aged 70-79 who lived in metropolitan areas. Dr. Ng's research colleagues were based at Curtin University and the Eye & Vision Epidemiology Research Group.

"We found cataract surgery reduced the frequency of all crashes by 12.6% after accounting for other potential confounders, " Dr. Ng said, "and the cost savings from this reduction amounted to AUD $4.3 million. Each operation saved about $150 in crash costs. By including all crashes rather than just fatal and hospitalization crashes, all possible benefits of cataract surgery were taken into account."

In Australia and other countries, people often have to wait weeks or months to receive surgery after cataract is diagnosed. This study argues that this delay significantly impacts not only patients' quality of life, but public safety and healthcare, and property costs. The authors say research is needed to compare crash rates before and after on patients' second eyes.

Explore further: Amgen misses 1Q views as higher costs cut profit

Provided by American Academy of Ophthalmology

not rated yet
add to favorites email to friend print save as pdf

Related Stories

Virtual trainer teaches residents cataract surgery

Feb 02, 2010

The Massachusetts Eye and Ear Infirmary Cataract Surgery Trainer, a virtual training tool which helps to train physicians to perform cataract surgery, has been shown to enhance teaching in cataract surgery when compared to ...

The world's most common operation

Nov 09, 2009

As many as 10 million people around the world suffer from cataracts. Thomas Kohnen of the Goethe University in Frankfurt and his coauthors discuss cataract surgery with the implantation of an artificial lens in the current ...

Recommended for you

Amgen misses 1Q views as higher costs cut profit

Apr 22, 2014

Despite higher sales, biotech drugmaker Amgen's first-quarter profit fell 25 percent as production and research costs rose sharply, while the year-ago quarter enjoyed a tax benefit. The company badly missed ...

Valeant, Ackman make $45.6B Allergan bid

Apr 22, 2014

Valeant Pharmaceuticals and activist investor Bill Ackman have unveiled details of their offer to buy Botox maker Allergan, proposing a cash-and-stock deal that could be worth about $45.6 billion.

User comments : 0

More news stories

Man among first in US to get 'bionic eye' (Update)

A degenerative eye disease slowly robbed Roger Pontz of his vision. Diagnosed with retinitis pigmentosa as a teenager, Pontz has been almost completely blind for years. Now, thanks to a high-tech procedure ...